
Amsterdam’s ADORE Secures €9M to tackle cancer and neurodegenerative diseases
ADORE to unite thousands of researchers to address major healthcare challenges
Amsterdam's prominence in life sciences and medical research has received a major boost, as the Dutch Research Council (NWO) awarded €9 million to ADORE as part of its Long Term Program.
The Long Term Program, a 10-year project, will bring together over 2,000 researchers from Cancer Center Amsterdam and Amsterdam Neuroscience to develop personalised treatments by exploring shared disease mechanisms. It aims to improve life expectancy and quality of life as well as address the growing burden of care through collaborations between research institutions, industry, and society.
The investment comes amid projections that cancer cases in the Netherlands will rise from 800,000 in 2022 to 1.4 million by 2031. Meaning 1 in 2 Dutch residents could face a cancer diagnosis in their lifetime. Similarly, dementia rates are expected to affect 1 in 5 people, and multiple sclerosis diagnoses are averaging one per day. To address these challenges, NWO has committed €25 million in total funding across research initiatives.

Collaboration supports Amsterdam’s strong healthcare ecosystem
Amsterdam will host this effort through the ADORE Research & Diagnostics Center, set to become the world's largest onco-neuro campus. The €9 million grant, part of a larger €30 million, 10-year project supported by the ADORE foundation and other partners, adds to Amsterdam’s strong healthcare landscape and will help to address critical health challenges like cancer and dementia through personalised medicine. The city’s efforts are further supported by Amsterdam UMC, which is pushing AI-based research and recently became the first European hospital to complete a double wireless pacemaker operation.
Related articles

Government grants millions to develop groundbreaking 'Brain Atlas'

Amsterdam UMC leads €12 million lung cancer research project

Ellogon.AI secures €1M to advance immunotherapy innovation

ERC advanced grants awarded to multiple Amsterdam knowledge institutes

The Netherlands has ranked 8th in the Global Innovation Index 2024

Amsterdam’s LUMICKS lands €20M to revolutionise cancer drug discovery

Amsterdam-based startup Lapsi Health has just launched its AI-based stethoscope

Amsterdam's Kepler Vision Technologies receives €1.5M to increase support in healthcare

Clean Motion launches solar-powered EV pilot program in Amsterdam
